Articles by Alexandra Calmy

1 2 3 4 5

Human papillomavirus antibody response following HAART initiation among MSM

Combes, Jean-Damien; Clifford, Gary M.; Egger, Matthias; More

AIDS. 31(4):561-569, February 20th, 2017.

Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population

Gueler, Aysel; Moser, André; Calmy, Alexandra; More

AIDS. 31(3):427-436, January 28th, 2017.

The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV

Kohler, Philipp; Schmidt, Axel J.; Cavassini, Matthias; More

AIDS. 29(18):2509-2515, November 28th, 2015.

Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality

Glass, Tracy R.; Sterne, Jonathan A.C.; Schneider, Marie-Paule; More

AIDS. 29(16):2195-2200, October 23rd, 2015.

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa

Ciaffi, Laura; Koulla-Shiro, Sinata; Sawadogo, Adrien; More

AIDS. 29(12):1473-1481, July 31st, 2015.

Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland

Gueler, Aysel; Schoeni-Affolter, Franziska; Moser, André; More

AIDS. 29(2):231-238, January 14th, 2015.

Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients

Metzner, Karin J.; Scherrer, Alexandra U.; von Wyl, Viktor; More

AIDS. 28(15):2231-2239, September 24th, 2014.

Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis

Shubber, Zara; Calmy, Alexandra; Andrieux-Meyer, Isabelle; More

AIDS. 27(9):1403-1412, June 1st, 2013.

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

Young, Jim; Schäfer, Juliane; Fux, Christoph A.; More

AIDS. 26(5):567-575, March 13th, 2012.

A randomized crossover study to compare efavirenz and etravirine treatment

Nguyen, Alain; Calmy, Alexandra; Delhumeau, Cécile; More

AIDS. 25(1):57-63, January 2nd, 2011.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

Simioni, Samanta; Cavassini, Matthias; Annoni, Jean-Marie; More

AIDS. 24(9):1243-1250, June 1st, 2010.

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients

Mueller, Nicolas J; Fux, Christoph A; Ledergerber, Bruno; More

AIDS. 24(8):1127-1134, May 15th, 2010.

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

Calmy, Alexandra; Gayet-Ageron, Angèle; Montecucco, Fabrizio; More

AIDS. 23(8):929-939, May 15th, 2009.

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

Wand, Handan; Calmy, Alexandra; Carey, Dianne L; More

AIDS. 21(18):2445-2453, November 30th, 2007.

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

Laurent, Christian; Kouanfack, Charles; Koulla-Shiro, Sinata; More

AIDS. 21(6):768-771, March 30th, 2007.

Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine

Opravil, Milos; Baumann, Doris; Chave, Jean-Philippe; More

AIDS. 18(16):2213-2215, November 5th, 2004.

1 2 3 4 5